Boston Convention and Exhibition Center
November 11-15, 2025
Comprehensive Genomic Profiling Panel
An NGS-Based Test for Myeloid Leukemia
Because Waiting Shouldn't Be Part of Your Oncology Plan
When cancer is diagnosed, finding treatment options is the top priority
OncoTarget® Series is our comprehensive genomic profiling solution to identify targeted immunotherapies for advanced cancers – solid tumors or leukemias.
| GoPath® Diagnostics Launches FDA-Cleared CGP Test under OncoTarget® 500 OncoTarget®500 genomic profiling identifies tumor-based somatic mutations with high accuracy and sensitivity – single nucleotide variants (SNVs), small insertions and deletions, amplifications, translocations, microsatellite instability (MSI) and tumor mutation burden (TMB). Learn more |
